---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-038762"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2025-03-13T23:59:59+00:00"
generated_at: "2026-05-24T20:55:35.056041+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# HeartSciences Q3 FY2025 no revenue, cash $2.6M; FDA submission for MyoVista device expected H1 2025

## Summary
- No revenue for Q3 FY2025; cash and equivalents $2.6M, shareholders' equity $1.8M as of Jan 31, 2025.
- Final pre-submission meeting with FDA for MyoVista wavECG device completed Feb 2025; clinical validation within weeks, FDA submission targeted H1 2025.
- MyoVista Insights cloud platform Phase 1 completed Dec 2024; Phase 2 (AI-ECG reporting, subject to FDA clearance) targets submission H2 2025.
- Pre-validation work commenced with Rutgers on low ejection fraction algorithm licensed from Mount Sinai; aim for FDA submission H2 2025.
- CMS 2025 OPPS final rule includes AI-ECG reimbursement effective Jan 2025, enabling reimbursement upon commercial launch.

## SEC filing metadata
- accession: 0000950170-25-038762
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2025-03-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017025038762/0000950170-25-038762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017025038762/hscs-20250313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-038762
- JSON: https://secwatch.observer/filing/0000950170-25-038762.json
- Plain text: https://secwatch.observer/filing/0000950170-25-038762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.